Shuying Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Shuying Sun has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
Christine Tian
Department of Mathematics, Texas State University, San Marcos, Texas 78666, USA
3 shared publicationsAlice Zhong
2 shared publicationsAshley Pritchard
Kansas State University, Manhattan, Kansas 66506, USA
2 shared publicationsAustin Zane
Department of Statistics, Texas A&M University, College Station, TX, USA
2 shared publicationsCarolyn Fulton
Department of Mathematics, Schreiner University, Kerrville, TX, USA
2 shared publicationsEmma McFall
Brown University, Providence, Rhode Island 02912, USA
2 shared publications
Latest Publications
- Open Access
- 20 July 2026
- Published by Springer Nature in Journal of Statistical Theory and Practice
- Vol. 20 (3)
Comparative Analysis of Six Correlation Metrics on Identifying DNA Co-Methylation Patterns
DNA methylation is an important epigenetic event associated with cancers. Different genomic sites tend to be co-methylated. It is unclear which correlation metrics should be used to study co-methylation and how they perform in identifying highly co-methylated (HCM) sites. The impact of different features of the data is also unclear, e.g., outlier, low variance, and data transformation (from B to M = logit(B)). We therefore conducted comparative analyses of six metrics, Pearson, Spearman, Kendall, Hoeffding, Distance, and Maximal Information Coefficient (MIC). Key findings are summarized below. First, the numbers of HCM sites identified by the six metrics were very different when using a fixed cutoff value. Pearson and Distance identified more HCM sites and had strong similarities. However, these metrics were susceptible to outliers and data transformation. They identified more HCM sites when using B values, but these sites tended to have outliers and lower variance. Second, Kendall’s and Hoeffding’s scores were significantly lower than those of the other metrics, leading to fewer HCM pairs being identified. Third, MIC required a large sample size to perform effectively. Although it may detect unique correlation patterns, it is difficult to interpret these patterns biologically. In summary, considering many factors together (e.g., outliers, low variance, data transformation, cutoffs, and runtime), researchers should carefully evaluate the distinct strengths and limitations of each method to select the most appropriate one for their methylation data and the goal of their analysis.
- 20 July 2026
- Published by Springer Nature in Journal of Statistical Theory and Practice
- Vol. 20 (3)
Open AccessComparative Analysis of Six Correlation Metrics on Identifying DNA Co-Methylation Patterns
DNA methylation is an important epigenetic event associated with cancers. Different genomic sites tend to be co-methylated. It is unclear which correlation metrics should be used to study co-methylation and how they perform in identifying highly co-methylated (HCM) sites. The impact of different features of the data is also unclear, e.g., outlier, low variance, and data transformation (from B to M = logit(B)). We therefore conducted comparative analyses of six metrics, Pearson, Spearman, Kendall, Hoeffding, Distance, and Maximal Information Coefficient (MIC). Key findings are summarized below. First, the numbers of HCM sites identified by the six metrics were very different when using a fixed cutoff value. Pearson and Distance identified more HCM sites and had strong similarities. However, these metrics were susceptible to outliers and data transformation. They identified more HCM sites when using B values, but these sites tended to have outliers and lower variance. Second, Kendall’s and Hoeffding’s scores were significantly lower than those of the other metrics, leading to fewer HCM pairs being identified. Third, MIC required a large sample size to perform effectively. Although it may detect unique correlation patterns, it is difficult to interpret these patterns biologically. In summary, considering many factors together (e.g., outliers, low variance, data transformation, cutoffs, and runtime), researchers should carefully evaluate the distinct strengths and limitations of each method to select the most appropriate one for their methylation data and the goal of their analysis.
- Open Access
- 16 May 2026
- Published by Springer Nature in Statistics in Biosciences
Housekeeping Genes’ DNA Methylation Patterns in Breast and Endometrial Cancers
Little research has been conducted on housekeeping (HK) genes’ methylation patterns in breast cancer (BRCA) and uterine corpus endometrial carcinoma (UCEC). Using publicly available data, we conducted comprehensive analyses of HK genes’ methylation patterns at the cytosine guanine (CG) site level. Findings are summarized below. First, HK sites exhibited lower differential methylation (DM) rates than overall DM rates. UCEC demonstrated a higher DM rate than BRCA, and they shared a small percentage of DM sites and 18 common DM HK genes that are cancer-related. Second, DM sites’ locations were different between BRCA and UCEC, with notable disparities in CpG islands and shores. Third, UCEC had more highly co-methylated CG pairs than BRCA. Normal and tumor samples had different co-methylation distributions in both BRCA and UCEC. Fourth, some CG sites’ co-methylation patterns did change between normal and tumor, with some minor shifts regarding overall co-methylation differences between the Alive and Dead samples in both BRCA and UCEC. Fifth, only a small number of CG sites kept strong and stable co-methylation patterns in BRCA and UCEC, respectively, and these two cancers only shared a small percentage of these co-methylated CG sites. Despite the small common CG list, 11 HK genes and 27 non-HK genes were identified as common in BRCA and UCEC. 19 of these 38 genes were from the protocadherin gamma cluster (PCDHG@). Finally, 1 HK gene (CUX1) and 4 non-HK genes (TP73, FOXP1, BANP, and MIR199A1) may play dual roles as both oncogenes and tumor suppressor genes.
- 16 May 2026
- Published by Springer Nature in Statistics in Biosciences
Open AccessHousekeeping Genes’ DNA Methylation Patterns in Breast and Endometrial Cancers
Little research has been conducted on housekeeping (HK) genes’ methylation patterns in breast cancer (BRCA) and uterine corpus endometrial carcinoma (UCEC). Using publicly available data, we conducted comprehensive analyses of HK genes’ methylation patterns at the cytosine guanine (CG) site level. Findings are summarized below. First, HK sites exhibited lower differential methylation (DM) rates than overall DM rates. UCEC demonstrated a higher DM rate than BRCA, and they shared a small percentage of DM sites and 18 common DM HK genes that are cancer-related. Second, DM sites’ locations were different between BRCA and UCEC, with notable disparities in CpG islands and shores. Third, UCEC had more highly co-methylated CG pairs than BRCA. Normal and tumor samples had different co-methylation distributions in both BRCA and UCEC. Fourth, some CG sites’ co-methylation patterns did change between normal and tumor, with some minor shifts regarding overall co-methylation differences between the Alive and Dead samples in both BRCA and UCEC. Fifth, only a small number of CG sites kept strong and stable co-methylation patterns in BRCA and UCEC, respectively, and these two cancers only shared a small percentage of these co-methylated CG sites. Despite the small common CG list, 11 HK genes and 27 non-HK genes were identified as common in BRCA and UCEC. 19 of these 38 genes were from the protocadherin gamma cluster (PCDHG@). Finally, 1 HK gene (CUX1) and 4 non-HK genes (TP73, FOXP1, BANP, and MIR199A1) may play dual roles as both oncogenes and tumor suppressor genes.
- Open Access
- 22 April 2025
- Published by Springer Nature in Research Square
Comparative Analysis of Six Correlation Metrics on Identifying DNA Co-Methylation Patterns
DNA methylation is an important epigenetic event and is significantly associated with cancer. Different genomic sites tend to be co-methylated. It is unclear which correlation metrics should be used to study co-methylation and how different metrics perform in identifying highly co-methylated (HCM) sites. It is also unclear the impact of different features of the data, e.g., outlier, low variance, and data transformation (from B to M = logit(B)). We therefore conducted comprehensive analyses of six metrics, Pearson, Spearman, Kendall, Hoeffding, Distance, and Maximal Information Coefficient (MIC). Key findings are summarized below. First, the runtime of the six metrics drastically differed and increased with sample size, especially for MIC. Spearman and Pearson were much faster (with no missing data). Second, the numbers of HCM sites identified by the six metrics were very different. Pearson and Distance both identified more HCM sites and had strong similarities. However, these metrics were susceptible to outliers and data transformation. They identified more highly co-methylated sites when using B values, but these sites tended to have outliers and lower variance. Third, Kendall and Hoeffding's scores were significantly lower than other metrics’ correlation coefficients, making it difficult to identify HCM sites without a proper cutoff. Fourth, MIC required a large sample size to perform properly. Although it may detect unique correlation patterns, it is difficult to interpret these patterns biologically. Finally, considering all factors together (runtime, outlier, low variance, and data transformation), Spearman is relatively better for co-methylation analysis with no missing data.
- 22 April 2025
- Published by Springer Nature in Research Square
Open AccessComparative Analysis of Six Correlation Metrics on Identifying DNA Co-Methylation Patterns
DNA methylation is an important epigenetic event and is significantly associated with cancer. Different genomic sites tend to be co-methylated. It is unclear which correlation metrics should be used to study co-methylation and how different metrics perform in identifying highly co-methylated (HCM) sites. It is also unclear the impact of different features of the data, e.g., outlier, low variance, and data transformation (from B to M = logit(B)). We therefore conducted comprehensive analyses of six metrics, Pearson, Spearman, Kendall, Hoeffding, Distance, and Maximal Information Coefficient (MIC). Key findings are summarized below. First, the runtime of the six metrics drastically differed and increased with sample size, especially for MIC. Spearman and Pearson were much faster (with no missing data). Second, the numbers of HCM sites identified by the six metrics were very different. Pearson and Distance both identified more HCM sites and had strong similarities. However, these metrics were susceptible to outliers and data transformation. They identified more highly co-methylated sites when using B values, but these sites tended to have outliers and lower variance. Third, Kendall and Hoeffding's scores were significantly lower than other metrics’ correlation coefficients, making it difficult to identify HCM sites without a proper cutoff. Fourth, MIC required a large sample size to perform properly. Although it may detect unique correlation patterns, it is difficult to interpret these patterns biologically. Finally, considering all factors together (runtime, outlier, low variance, and data transformation), Spearman is relatively better for co-methylation analysis with no missing data.
- Open Access
- 1 January 2025
- Published by Maximum Academic Press in Epigenetics Insights
- Vol. 18 (1)
Statistical analysis of DNA methylation patterns of tumor suppressor genes in breast cancer
The purpose of this study was to conduct the first-ever comprehensive analysis of methylation patterns of tumor suppressor genes (TSGs) in breast cancer. The authors first identified differentially methylated (DM) sites between tumors and matched normal tissues in both Alive and Dead samples. They then analyzed co-methylation patterns related to these DM sites and reported corresponding TSGs and non-TSGs. First, tumors had more heterogeneous methylation sites than normal tissues (40% vs < 10%) in both Alive and Dead samples. Second, there were significantly more DM sites in Dead than in Alive samples. Third, as for co-methylation patterns, in normal tissues, some DM sites tended to have strong co-methylations with many CG sites. In tumor tissues, some of these strong co-methylations were lost, and some new co-methylation relationships were developed. These patterns were seen in both Alive and Dead data. Fourth, there were more co-methylation changes between normal and tumor tissues in Dead than in Alive samples. Thirty TSGs and 92 non-TSGs were identified as having notable differences between Alive and Dead data. Finally, seven TSGs were involved in many co-methylation changes between normal and tumor tissues. These seven TSGs were hub genes in different networks.
- 1 January 2025
- Published by Maximum Academic Press in Epigenetics Insights
- Vol. 18 (1)
Open AccessStatistical analysis of DNA methylation patterns of tumor suppressor genes in breast cancer
The purpose of this study was to conduct the first-ever comprehensive analysis of methylation patterns of tumor suppressor genes (TSGs) in breast cancer. The authors first identified differentially methylated (DM) sites between tumors and matched normal tissues in both Alive and Dead samples. They then analyzed co-methylation patterns related to these DM sites and reported corresponding TSGs and non-TSGs. First, tumors had more heterogeneous methylation sites than normal tissues (40% vs < 10%) in both Alive and Dead samples. Second, there were significantly more DM sites in Dead than in Alive samples. Third, as for co-methylation patterns, in normal tissues, some DM sites tended to have strong co-methylations with many CG sites. In tumor tissues, some of these strong co-methylations were lost, and some new co-methylation relationships were developed. These patterns were seen in both Alive and Dead data. Fourth, there were more co-methylation changes between normal and tumor tissues in Dead than in Alive samples. Thirty TSGs and 92 non-TSGs were identified as having notable differences between Alive and Dead data. Finally, seven TSGs were involved in many co-methylation changes between normal and tumor tissues. These seven TSGs were hub genes in different networks.
- 2 December 2024
- Published by Springer Nature in Statistics in Biosciences
- Vol. 18 (1) , 234-265
Mcperturb: A New 5-step Multicollinearity Diagnostic Method Developed Based on Existing Methods
- 2 December 2024
- Published by Springer Nature in Statistics in Biosciences
- Vol. 18 (1) , 234-265
Mcperturb: A New 5-step Multicollinearity Diagnostic Method Developed Based on Existing Methods
- Open Access
- 29 June 2023
- Published by Springer Nature in BMC Genomic Data
- Vol. 24 (1) , 1-20
Pairwise comparative analysis of six haplotype assembly methods based on users’ experience
A haplotype is a set of DNA variants inherited together from one parent or chromosome. Haplotype information is useful for studying genetic variation and disease association. Haplotype assembly (HA) is a process of obtaining haplotypes using DNA sequencing data. Currently, there are many HA methods with their own strengths and weaknesses. This study focused on comparing six HA methods or algorithms: HapCUT2, MixSIH, PEATH, WhatsHap, SDhaP, and MAtCHap using two NA12878 datasets named hg19 and hg38. The 6 HA algorithms were run on chromosome 10 of these two datasets, each with 3 filtering levels based on sequencing depth (DP1, DP15, and DP30). Their outputs were then compared. Run time (CPU time) was compared to assess the efficiency of 6 HA methods. HapCUT2 was the fastest HA for 6 datasets, with run time consistently under 2 min. In addition, WhatsHap was relatively fast, and its run time was 21 min or less for all 6 datasets. The other 4 HA algorithms’ run time varied across different datasets and coverage levels. To assess their accuracy, pairwise comparisons were conducted for each pair of the six packages by generating their disagreement rates for both haplotype blocks and Single Nucleotide Variants (SNVs). The authors also compared them using switch distance (error), i.e., the number of positions where two chromosomes of a certain phase must be switched to match with the known haplotype. HapCUT2, PEATH, MixSIH, and MAtCHap generated output files with similar numbers of blocks and SNVs, and they had relatively similar performance. WhatsHap generated a much larger number of SNVs in the hg19 DP1 output, which caused it to have high disagreement percentages with other methods. However, for the hg38 data, WhatsHap had similar performance as the other 4 algorithms, except SDhaP. The comparison analysis showed that SDhaP had a much larger disagreement rate when it was compared with the other algorithms in all 6 datasets. The comparative analysis is important because each algorithm is different. The findings of this study provide a deeper understanding of the performance of currently available HA algorithms and useful input for other users.
- 29 June 2023
- Published by Springer Nature in BMC Genomic Data
- Vol. 24 (1) , 1-20
Open AccessPairwise comparative analysis of six haplotype assembly methods based on users’ experience
A haplotype is a set of DNA variants inherited together from one parent or chromosome. Haplotype information is useful for studying genetic variation and disease association. Haplotype assembly (HA) is a process of obtaining haplotypes using DNA sequencing data. Currently, there are many HA methods with their own strengths and weaknesses. This study focused on comparing six HA methods or algorithms: HapCUT2, MixSIH, PEATH, WhatsHap, SDhaP, and MAtCHap using two NA12878 datasets named hg19 and hg38. The 6 HA algorithms were run on chromosome 10 of these two datasets, each with 3 filtering levels based on sequencing depth (DP1, DP15, and DP30). Their outputs were then compared. Run time (CPU time) was compared to assess the efficiency of 6 HA methods. HapCUT2 was the fastest HA for 6 datasets, with run time consistently under 2 min. In addition, WhatsHap was relatively fast, and its run time was 21 min or less for all 6 datasets. The other 4 HA algorithms’ run time varied across different datasets and coverage levels. To assess their accuracy, pairwise comparisons were conducted for each pair of the six packages by generating their disagreement rates for both haplotype blocks and Single Nucleotide Variants (SNVs). The authors also compared them using switch distance (error), i.e., the number of positions where two chromosomes of a certain phase must be switched to match with the known haplotype. HapCUT2, PEATH, MixSIH, and MAtCHap generated output files with similar numbers of blocks and SNVs, and they had relatively similar performance. WhatsHap generated a much larger number of SNVs in the hg19 DP1 output, which caused it to have high disagreement percentages with other methods. However, for the hg38 data, WhatsHap had similar performance as the other 4 algorithms, except SDhaP. The comparison analysis showed that SDhaP had a much larger disagreement rate when it was compared with the other algorithms in all 6 datasets. The comparative analysis is important because each algorithm is different. The findings of this study provide a deeper understanding of the performance of currently available HA algorithms and useful input for other users.
- Open Access
- 29 June 2023
- Published by Springer Nature in Research Square
Statistical analysis of DNA methylation patterns of tumor suppressor genes for breast cancer
Background Breast cancer is associated with DNA methylation, an epigenetic event in which a methyl group is covalently bonded to a cytosine-guanine (CG) pair. Although previous research has studied methylation patterns of individual tumor suppressor genes (TSGs), there has not been a comprehensive analysis of all available TSGs for breast cancer. The purpose of this study is to conduct the first-ever comprehensive statistical analysis of methylation patterns for all 1,217 TSGs. The authors analyzed publicly available Illumina 450K array data for 53 living (53-Alive) and 32 deceased (32-Dead) breast cancer patients. First, they studied the overall methylation distribution. They then identified differentially methylated (DM) sites between tumors and matched normal tissues in both Alive and Dead samples. They analyzed co-methylation patterns related to these DM sites and reported corresponding TSGs and non-TSGs. Results Below are the key findings of this study. First, tumor tissues had more heterogeneous methylation sites than normal tissues (40% vs. <10%) in both Alive and Dead samples. Second, there were significantly more DM sites in Dead than in Alive samples. Third, co-methylation patterns were investigated by calculating the Spearman correlation coefficients between each DM site and all 391,459 CG sites for both Alive and Dead samples. In normal tissues, some DM sites tended to have strong co-methylation with many other CG sites. In tumor tissues, some of these strong co-methylations were lost and some new co-methylation relationships were developed. These patterns were seen in both Alive and Dead data. Fourth, there were more co-methylation changes between normal and tumor tissues in Dead than in Alive samples. 30 TSGs and 92 non-TSGs were identified as having notable differences between Alive and Dead data. Finally, ESR1, PAX6, ZIC1, TP73, PPP1CA, POU6F2, and TFAP2A were involved in many different co-methylation changes between normal and tumor tissues. These 7 TSGs played a key role as hub genes in different networks. Conclusion Significant differences were identified for various methylation-pattern changes between normal and tumor as well as between Alive and Dead samples. These differences can be used to identify novel TSGs and biomarkers to improve breast cancer study.
- 29 June 2023
- Published by Springer Nature in Research Square
Open AccessStatistical analysis of DNA methylation patterns of tumor suppressor genes for breast cancer
Background Breast cancer is associated with DNA methylation, an epigenetic event in which a methyl group is covalently bonded to a cytosine-guanine (CG) pair. Although previous research has studied methylation patterns of individual tumor suppressor genes (TSGs), there has not been a comprehensive analysis of all available TSGs for breast cancer. The purpose of this study is to conduct the first-ever comprehensive statistical analysis of methylation patterns for all 1,217 TSGs. The authors analyzed publicly available Illumina 450K array data for 53 living (53-Alive) and 32 deceased (32-Dead) breast cancer patients. First, they studied the overall methylation distribution. They then identified differentially methylated (DM) sites between tumors and matched normal tissues in both Alive and Dead samples. They analyzed co-methylation patterns related to these DM sites and reported corresponding TSGs and non-TSGs. Results Below are the key findings of this study. First, tumor tissues had more heterogeneous methylation sites than normal tissues (40% vs. <10%) in both Alive and Dead samples. Second, there were significantly more DM sites in Dead than in Alive samples. Third, co-methylation patterns were investigated by calculating the Spearman correlation coefficients between each DM site and all 391,459 CG sites for both Alive and Dead samples. In normal tissues, some DM sites tended to have strong co-methylation with many other CG sites. In tumor tissues, some of these strong co-methylations were lost and some new co-methylation relationships were developed. These patterns were seen in both Alive and Dead data. Fourth, there were more co-methylation changes between normal and tumor tissues in Dead than in Alive samples. 30 TSGs and 92 non-TSGs were identified as having notable differences between Alive and Dead data. Finally, ESR1, PAX6, ZIC1, TP73, PPP1CA, POU6F2, and TFAP2A were involved in many different co-methylation changes between normal and tumor tissues. These 7 TSGs played a key role as hub genes in different networks. Conclusion Significant differences were identified for various methylation-pattern changes between normal and tumor as well as between Alive and Dead samples. These differences can be used to identify novel TSGs and biomarkers to improve breast cancer study.
- Open Access
- 11 July 2022
- Published by Springer Nature in Research Square
Pairwise comparative analysis of six haplotype assembly methods based on users’ experience
Background. A haplotype is a set of DNA variants inherited together from one parent or chromosome. Haplotype information is useful for studying genetic variation and disease association. Haplotype assembly (HA) is to obtain haplotypes using DNA sequencing data. Currently, there are many HA methods with their own strengths and weaknesses. In this paper, we focus on comparing six HA methods or algorithms: HapCUT2, MixSIH, PEATH, WhatsHap, SDhaP, and MAtCHap using two NA12878 sequencing datasets named hg19 and hg38. We run the 6 HA algorithms on chromosome 10 of these two datasets, each with 3 filtering levels based on sequencing depth (DP1, DP15, and DP30), and then compare them. Result. To assess 6 HA methods’ efficiency, we compare their run time. HapCUT2 is the fastest HA for 6 datasets, with run time always under 2 minutes. In addition, WhatsHap is relatively fast and its run time is always less than about 20 minutes for all 6 datasets. The other 4 HA algorithms’ run time may vary across different datasets and coverage levels. To assess their accuracy, we perform pairwise comparisons for each pair of the six packages by generating their disagreement rates for both haplotype blocks and single nucleotide variants (SNVs). We also compare them using switch distance (error), which is the number of positions where two chromosomes of a certain phase must be switched to match with the known haplotype or another phase. We find that HapCUT2, PEATH, MixSIH, and MAtCHap generate output files with similar numbers of blocks and SNVs, and they have relatively similar performance. In addition, we find that WhatsHap generates a much larger number of SNVs in the hg19 DP1 output, causing it to have high disagreement percentages with other methods. However, when using the hg38 data, WhatsHap has similar performance as the other 4 algorithms, except SDhaP. We find that SDhaP has much larger disagreements with the other algorithms in all 6 datasets. Conclusion. The comparative analysis is important because each algorithm is different. Our findings provide a deeper understanding of the performance of currently available HA algorithms and useful input for other users.
- 11 July 2022
- Published by Springer Nature in Research Square
Open AccessPairwise comparative analysis of six haplotype assembly methods based on users’ experience
Background. A haplotype is a set of DNA variants inherited together from one parent or chromosome. Haplotype information is useful for studying genetic variation and disease association. Haplotype assembly (HA) is to obtain haplotypes using DNA sequencing data. Currently, there are many HA methods with their own strengths and weaknesses. In this paper, we focus on comparing six HA methods or algorithms: HapCUT2, MixSIH, PEATH, WhatsHap, SDhaP, and MAtCHap using two NA12878 sequencing datasets named hg19 and hg38. We run the 6 HA algorithms on chromosome 10 of these two datasets, each with 3 filtering levels based on sequencing depth (DP1, DP15, and DP30), and then compare them. Result. To assess 6 HA methods’ efficiency, we compare their run time. HapCUT2 is the fastest HA for 6 datasets, with run time always under 2 minutes. In addition, WhatsHap is relatively fast and its run time is always less than about 20 minutes for all 6 datasets. The other 4 HA algorithms’ run time may vary across different datasets and coverage levels. To assess their accuracy, we perform pairwise comparisons for each pair of the six packages by generating their disagreement rates for both haplotype blocks and single nucleotide variants (SNVs). We also compare them using switch distance (error), which is the number of positions where two chromosomes of a certain phase must be switched to match with the known haplotype or another phase. We find that HapCUT2, PEATH, MixSIH, and MAtCHap generate output files with similar numbers of blocks and SNVs, and they have relatively similar performance. In addition, we find that WhatsHap generates a much larger number of SNVs in the hg19 DP1 output, causing it to have high disagreement percentages with other methods. However, when using the hg38 data, WhatsHap has similar performance as the other 4 algorithms, except SDhaP. We find that SDhaP has much larger disagreements with the other algorithms in all 6 datasets. Conclusion. The comparative analysis is important because each algorithm is different. Our findings provide a deeper understanding of the performance of currently available HA algorithms and useful input for other users.
- Open Access
- 15 April 2022
- Published by Springer Nature in BMC Genomic Data
- Vol. 23 (1) , 1-23
Thorough statistical analyses of breast cancer co-methylation patterns
Background: Breast cancer is one of the most commonly diagnosed cancers. It is associated with DNA methylation, an epigenetic event with a methyl group added to a cytosine paired with a guanine, i.e., a CG site. The methylation levels of different genes in a genome are correlated in certain ways that affect gene functions. This correlation pattern is known as co-methylation. It is still not clear how different genes co-methylate in the whole genome of breast cancer samples. Previous studies are conducted using relatively small datasets (Illumina 27K data). In this study, we analyze much larger datasets (Illumina 450K data). Results: Our key findings are summarized below. First, normal samples have more highly correlated, or co-methylated, CG pairs than tumor samples. Both tumor and normal samples have more than 93% positive co-methylation, but normal samples have significantly more negatively correlated CG sites than tumor samples (6.6% vs. 2.8%). Second, both tumor and normal samples have about 94% of co-methylated CG pairs on different chromosomes, but normal samples have 470 million more CG pairs. Highly co-methylated pairs on the same chromosome tend to be close to each other. Third, a small proportion of CG sites’ co-methylation patterns change dramatically from normal to tumor. The percentage of differentially methylated (DM) sites among them is larger than the overall DM rate. Fourth, certain CG sites are highly correlated with many CG sites. The top 100 of such super-connector CG sites in tumor and normal samples have no overlaps. Fifth, both highly changing sites and super-connector sites’ locations are significantly different from the genome-wide CG sites’ locations. Sixth, chromosome X co-methylation patterns are very different from other chromosomes. Finally, the network analyses of genes associated with several sets of co-methylated CG sites identified above show that tumor and normal samples have different patterns. Conclusions: Our findings will provide researchers with a new understanding of co-methylation patterns in breast cancer. Our ability to thoroughly analyze co-methylation of large datasets will allow researchers to study relationships and associations between different genes in breast cancer.
- 15 April 2022
- Published by Springer Nature in BMC Genomic Data
- Vol. 23 (1) , 1-23
Open AccessThorough statistical analyses of breast cancer co-methylation patterns
Background: Breast cancer is one of the most commonly diagnosed cancers. It is associated with DNA methylation, an epigenetic event with a methyl group added to a cytosine paired with a guanine, i.e., a CG site. The methylation levels of different genes in a genome are correlated in certain ways that affect gene functions. This correlation pattern is known as co-methylation. It is still not clear how different genes co-methylate in the whole genome of breast cancer samples. Previous studies are conducted using relatively small datasets (Illumina 27K data). In this study, we analyze much larger datasets (Illumina 450K data). Results: Our key findings are summarized below. First, normal samples have more highly correlated, or co-methylated, CG pairs than tumor samples. Both tumor and normal samples have more than 93% positive co-methylation, but normal samples have significantly more negatively correlated CG sites than tumor samples (6.6% vs. 2.8%). Second, both tumor and normal samples have about 94% of co-methylated CG pairs on different chromosomes, but normal samples have 470 million more CG pairs. Highly co-methylated pairs on the same chromosome tend to be close to each other. Third, a small proportion of CG sites’ co-methylation patterns change dramatically from normal to tumor. The percentage of differentially methylated (DM) sites among them is larger than the overall DM rate. Fourth, certain CG sites are highly correlated with many CG sites. The top 100 of such super-connector CG sites in tumor and normal samples have no overlaps. Fifth, both highly changing sites and super-connector sites’ locations are significantly different from the genome-wide CG sites’ locations. Sixth, chromosome X co-methylation patterns are very different from other chromosomes. Finally, the network analyses of genes associated with several sets of co-methylated CG sites identified above show that tumor and normal samples have different patterns. Conclusions: Our findings will provide researchers with a new understanding of co-methylation patterns in breast cancer. Our ability to thoroughly analyze co-methylation of large datasets will allow researchers to study relationships and associations between different genes in breast cancer.
- Open Access
- 20 December 2021
- Published by Springer Nature in Research Square
Thorough Statistical Analyses of Breast Cancer Co-Methylation Patterns
Background: Breast cancer is one of the most commonly diagnosed cancers. It is associated with DNA methylation, an epigenetic event with a methyl group added to a cytosine paired with a guanine, i.e., a CG site. The methylation levels of different genes in a genome are correlated in certain ways that affect gene functions. This correlation pattern is known as co-methylation. It is still not clear how different genes co-methylate in the whole genome of breast cancer samples. Previous studies are conducted using relatively small datasets (Illumina 27K data). In this study, we analyze much larger datasets (Illumina 450K data). Results: Our key findings are summarized below. First, normal samples have more highly correlated, or co-methylated, CG pairs than tumor samples. Both tumor and normal have more than 93% of positive co-methylation, but normal samples have significantly more negatively correlated CG sites than tumor samples (6.6% vs. 2.8%). Second, both tumor and normal samples have about 94% of co-methylated CG pairs on different chromosomes, but normal samples have 470 million more CG pairs. Highly co-methylated pairs on the same chromosome tend to be close to each other. Third, a small proportion of CG sites’ co-methylation patterns change dramatically from normal to tumor. The percentage of differentially methylated (DM) sites among them is larger than the overall DM rate. Fourth, certain CG sites are highly correlated with many CG sites; the top 100 of such super-connector CG sites in tumor and normal samples have no overlaps. Fifth, both highly changing sites and super-connector sites’ locations are significantly different from the genome-wide CG sites’ locations. Sixth, chromosome X co-methylation patterns are very different from other chromosomes. Finally, the network analyses of genes associated with several sets of co-methylated CG sites identified above show that tumor and normal samples have different patterns. Conclusions: Our findings will provide researchers with a new understanding of co-methylation patterns in breast cancer. Our ability to thoroughly analyze co-methylation of large datasets will allow researchers to study relationships and associations between different genes in breast cancer.
- 20 December 2021
- Published by Springer Nature in Research Square
Open AccessThorough Statistical Analyses of Breast Cancer Co-Methylation Patterns
Background: Breast cancer is one of the most commonly diagnosed cancers. It is associated with DNA methylation, an epigenetic event with a methyl group added to a cytosine paired with a guanine, i.e., a CG site. The methylation levels of different genes in a genome are correlated in certain ways that affect gene functions. This correlation pattern is known as co-methylation. It is still not clear how different genes co-methylate in the whole genome of breast cancer samples. Previous studies are conducted using relatively small datasets (Illumina 27K data). In this study, we analyze much larger datasets (Illumina 450K data). Results: Our key findings are summarized below. First, normal samples have more highly correlated, or co-methylated, CG pairs than tumor samples. Both tumor and normal have more than 93% of positive co-methylation, but normal samples have significantly more negatively correlated CG sites than tumor samples (6.6% vs. 2.8%). Second, both tumor and normal samples have about 94% of co-methylated CG pairs on different chromosomes, but normal samples have 470 million more CG pairs. Highly co-methylated pairs on the same chromosome tend to be close to each other. Third, a small proportion of CG sites’ co-methylation patterns change dramatically from normal to tumor. The percentage of differentially methylated (DM) sites among them is larger than the overall DM rate. Fourth, certain CG sites are highly correlated with many CG sites; the top 100 of such super-connector CG sites in tumor and normal samples have no overlaps. Fifth, both highly changing sites and super-connector sites’ locations are significantly different from the genome-wide CG sites’ locations. Sixth, chromosome X co-methylation patterns are very different from other chromosomes. Finally, the network analyses of genes associated with several sets of co-methylated CG sites identified above show that tumor and normal samples have different patterns. Conclusions: Our findings will provide researchers with a new understanding of co-methylation patterns in breast cancer. Our ability to thoroughly analyze co-methylation of large datasets will allow researchers to study relationships and associations between different genes in breast cancer.